Objectives: To determine the minimal important difference (MID) of the International Prostate Symptom Score (IPSS) and the Overactive Bladder Questionnaire short form (OAB-q SF) assessed in primary care among patients treated for lower urinary tract symptoms (LUTS).
Design: Single-arm, open-label observational cohort study with a 6-week follow-up.
Setting: Twenty-two pharmacies in the Netherlands.